A Novel LC System Embeds Analytes in Pre-formed Gradients for Rapid, Ultra-robust Proteomics.

Bache N, Geyer PE, Bekker-Jensen DB, Hoerning O, Falkenby L, Treit PV, Doll S, Paron I, Müller JB, Meier F, Olsen JV, Vorm O, Mann M. · 2018

Read A Novel LC System Embeds Analytes in Pre-formed Gradients for Rapid, Ultra-robust Proteomics. by Bache N, Geyer PE, Bekker-Jensen DB, Hoerning O, Falkenby L, Treit PV, Doll S, Paron I, Müller JB, Meier F, Olsen JV, Vorm O, Mann M. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6210218.txt.

Introduction

Bache and co-authors present a new liquid chromatography system for proteomics. Proteomics measures thousands of proteins in a sample. The liquid step before mass spectrometry is often slow. It can also lack robustness. The work appeared in Molecular and Cellular Proteomics. The system is sold as Evosep One.

The design uses gradients formed in advance. Samples sit inside those ready gradients. A second trick refocuses peptides with offset gradients. The team ran more than 2,000 HeLa samples to test it. Crude plasma samples showed no cross-contamination. The system measured over 5,000 proteins per sample. Each run took just 21 minutes. The authors say this speed suits clinical work.

Catalog record

CREATORBache N, Geyer PE, Bekker-Jensen DB, Hoerning O, Falkenby L, Treit PV, Doll S, Paron I, Müller JB, Meier F, Olsen JV, Vorm O, Mann M.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6210218

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A Novel LC System Embeds Analytes in Pre-formed Gradients for Rapid, Ultra-robust Proteomics* By Nicolai Bache, Philipp E. Geyer, Dorte B. Bekker-Jensen, Ole Hoerning, Lasse Falkenby, Peter V. Treit, Sophia Doll, Igor Paron, Johannes B. Müller, Florian Meier, Jesper V. Olsen, Ole Vorm Published in: Molecular & Cellular Proteomics : MCP DOI: 10.1074/mcp.TIR118.000853 ABSTRACT Because of low throughput and limited robustness, nano-scale liquid chromatography has been a bottleneck for advancing proteomics in biomedical research. Here, we developed and evaluated two new LC concepts—“pre-formed gradients” and “offset gradients for peptide re-focusing”—that are both implemented in the Evosep One instrument. We evaluated robustness with more than 2000 HeLa runs, demonstrated absence of cross-contamination with crude plasma samples, high proteome coverage by fractionated HeLa and routinely measuring more than 5000 proteins/sample in just 21 minutes. Bottom-up proteomics is a highly successful and generic technology, which now allows the analysis of complex samples ranging from bacteria through cell line systems and even human tissue samples (1). State-of-the-art workflows begin with a robust sample preparation to digest proteins and harvest purified peptides (2), which are separated by a liquid chromatography (LC)1 system before they are analyzed by a mass spectrometer (MS). Established software solutions automatically interpret the acquired spectra, generating lists of thousands of quantified proteins (3–8). The current performance level is a result of improvements not only in the mass spectrometric components but also the chromatographic part of the LC-MS workflow. In the quest for ever increasing chromatographic separation power, columns have become longer and particle sizes smaller - now reaching the sub 2 μm range. This may require pump pressures more than 1000 bar, presenting great engineering challenges for both the pumps and the entire LC system, often limiting robustness in routine operation. Thus, chromatography remains a weak link in MS-based proteomics workflows, leading to calls for new approaches (9). Furthermore, irreproducibility of retention times within and between laboratories severely limits strategies that rely on the transfer of accurate retention times, especially targeted proteomics (10), data independent acquisition (11) and “match between runs” at the MS level (12, 13). There is great interest in applying the increasing power of MS-based proteomics to diagnostic and clinical questions (14). “Clinical proteomics”, however, requires far more stability and reproducibility than that available even in the most advanced MS-based proteomics laboratories. Note that irreproducibility and robustness issues are not features of LC-MS per se, as the measurement of small molecules is firmly established in clinical laboratories around the world, which routinely measure hundreds of samples per day. The two key differences of these LC systems to the one applied in proteomics are their much larger column diameters (20-fold) and flow rates (1000-fold), making them much easier to control and less error-prone. Increasing the flow rates to achieve greater robustness has already been advocated in the context of cancer proteomics (15). However, the signal intensity in electrospray ionization is concentration dependent and reducing sensitivity at higher flow rates, which limits these approaches to a few μl/min. Apart from high robustness, throughput is the other central requirement for MS-based proteomics, if it is to enter routine clinical use. Instead, current proteomics workflows generally employ fractionation—multiplying measurement time—or use relatively long gradient times. In a recent large-scale plasma proteomics study measured in our laboratory, involving more than a thousand samples, 80% of the overall down time was attributable to the HPLC system rather than the MS. At the same time, column equilibration, loading and washing steps between runs limited the attractiveness of very short gradients (16, 17). Several years ago, some of the current authors devised a very different sample loading and injection approach. Termed speLC, for solid-phase-extraction (nano) liquid chromatography, it was intended for very high sample throughput needed for clinical application (18). The speLC made use of the same StageTips that are commonly employed in proteomics for micro-scale purification of peptides and crude manual fractionation (19–21). Instead of eluting into the autosampler vial of the HPLC system, a low-pressure pump passed a 5–10 min gradient through the StageTip itself and directly toward the MS. The speLC system can analyze 192 E. coli samples in only 30 h, as well as identifying more than 500 proteins from a HeLa cell lysate in less than 10 min (18). In subsequent work, speLC was combined with pre-fractionation such as 1D gel electrophoresis or strong cation exchange (SCX), capitalizing on its ability to analyze each of the fractions in 10 min or less (22). Although useful for simple protein mixtures, the low-pressure elution from StageTips and use of only very short analytical columns inherently limited chromatographic separation power of this system. In the work reported here, we aimed to preserve the benefits of the original speLC device while also achieving the desirable features of modern HPLC instruments. We realized this goal by coupling elution through the StageTips to a novel downstream workflow. In the Evosep One design, peptides are eluted at low pressure and flow rates of tens of μl/min from a special StageTip - termed EvotipTM. Notably, the gradient along with the eluted analytes are captured in a long capillary loop. A single high-pressure pump then applies the stored gradient to an analytical nano-scale column. This results in undiminished chromatographic separation performance while eliminating the need to form a gradient at high pressure. Thus, this layout marries the convenience and robustness of large columns, high-flow systems with the sensitivity of narrow column diameters and low-flow rates of nano-LC systems. We further detail the principle of operation and development of the Evosep instrument in detail and investigate its robustness, throughput, and reproducibility in typical applications encountered in MS-based proteomics. EXPERIMENTAL PROCEDURES Description of the Liquid Chromatography System The Evosep One incorporates four low-pressure single stroke piston pumps (A, B, C, and D) and one high-pressure single stroke piston pump (HP) (Fig. 1A; supplemental Fig. S1A, S1B). Together they create a separate low- and high-pressure sub-system. Each pump is equipped with a pressure and flow sensor to monitor and precisely control the flow of the individual solvent. A custom 12-port valve (operating at low-pressure) diverts the flow of the low-pressure pumps either toward the solvent bottles (sol A, sol B) for refilling or toward the system for analysis. The high-pressure pump has a separate 6-port valve (operating at high-pressure) for refilling. The only common flow path is a storage loop, which is either connected to the low- or high-pressure sub-system and is controlled by a 6-port rotary valve (Fig. 1A). In this way, the high-pressure sub-system is always connected to the analytical or separation column but is either in-line or bypasses the storage loop. In contrast, the low-pressure sub-system is always connected to waste but either in-line or bypassing the storage loop. Thus, the storage loop becomes the bridge between the low- and high-pressure sub-systems. [Figure: Evosep One flow diagram and time schedule. A, Almost all of the system runs at low pressure (10–20 bar), increasing the lifetime and robustness of the LC. Only a single pump and flow path operates at high pressure and this does not involve any solvent mixing. B, Stepwise timetable including all steps that the Evosep One is performing during a LC-MS run for the 60 samples/day method.

Read the complete text